Diagnostic Microbiology and Infectious Disease

Papers
(The H4-Index of Diagnostic Microbiology and Infectious Disease is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review257
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)77
The use of copper to help prevent transmission of SARS-coronavirus and influenza viruses. A general review69
Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays51
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals50
Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection center42
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection40
Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples38
COVID-19 in Brazil: 150,000 deaths and the Brazilian underreporting38
The risk factors associated with MERS-CoV patient fatality: A global survey37
In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units36
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type36
How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory35
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection34
Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities31
The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis.31
COVID-19 – 6 million cases worldwide and an overview of the diagnosis in Brazil: a tragedy to be announced30
Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-1928
Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: a cohort study28
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies28
Comparison of ceftazidime-avibactam and ceftolozane-tazobactam in vitro activities when tested against gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medica27
Vaginal bacterial profiles of aerobic vaginitis: a case–control study26
Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples25
Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (25
Activity of aztreonam in combination with ceftazidime–avibactam against serine- and metallo-β-lactamase–producing Pseudomonas aeruginosa25
Changes in healthcare managing COVID and non–COVID-19 patients during the pandemic: striking the balance25
0.05639386177063